Health and Ageing Litigation

MinterEllison brings to our health and ageing sector clients expertise gained in acting in some of Australia's most significant commercial cases. We understand the risks, costs and distraction from our client's core activities that litigation can bring and our aim is to give a clear assessment of the risks and chances of success and options for bringing about an early resolution of the dispute.

As a full service health practice, our health team comprises lawyers with extensive litigation experience in all areas of the sector. Medical malpractice litigation comprises the bulk of the health teams litigation workload and extends across the entire spectrum of claims. As key advisors to our health industry clients, we are often called upon at an early stage following a clinical incident to provide risk management advice, respond to patient complaints, assist in the pre-litigation phase and where necessary, defend litigated claims. As such, our lawyers have developed a proven track record identifying meritorious claims, evaluating risk and defending those claims where these is no exposure for our clients.

Our lawyers have acted for commercial insurers in respect of injuries sustained by patients and visitors and for medical products manufacturers in the defence of sensitive product liability actions and in claims arising out of defective medical prosthesis. In addition, our lawyers have experience in both prosecuting and defending health care providers being investigated or prosecuted by their relevant registration boards.

Disclaimer: Some of the information on this page refers to our experience in Australian States and Territories other than New South Wales. Due to advertising restrictions in New South Wales, we are prohibited from publishing information about some of the legal services which we provide in that State.

16 January 2013

On 31 December 2012, the China International Economic and Trade Arbitration Commission (CIETAC), a foreign-related arbitration commission set up by the China Council for the Promotion of International Trade (also known as the China Chamber of International Commerce) (CCPIT), released its Announcement on Issues Concerning CIETAC Shanghai Sub-Commission and CIETAC South China Sub-Commission" (the Latest Announcement). This is the latest development in a dispute, which has been on foot since April 2012, between CIETAC, the Shanghai Sub-Commission of CIETAC (CIETAC Shanghai), and the Shenzhen Court of International Arbitration (SCIA) (the CIETAC Dispute). SCIA was known as the South China Sub-Commission of CIETAC before 22 October 2012.

1 December 2011

On Tuesday, 29 November 2011, as part of its Mid-Year Economic and Fiscal Outlook 2011-12, the Federal Government announced a package of changes intended to raise A$11.5 billion in new revenue and savings.